Format

Send to

Choose Destination
Int J Infect Dis. 2018 Dec;77:107-112. doi: 10.1016/j.ijid.2018.10.009. Epub 2018 Oct 17.

Achieving sustainable development goals for HIV/AIDS in the Republic of the Congo - Progress, obstacles and challenges in HIV/AIDS health services.

Author information

1
Institut National de Recherche en Sciences de la Santé (IRSSA), Brazzaville, Congo; Fondation Congolaise pour la Recherche Médicale (FCRM), Brazzaville, Congo.
2
Clinique Laennec, Malakoff, France.
3
School of Life Sciences, University of Lincoln, Lincoln, UK.
4
Centre for Clinical Microbiology, Division of Infection and Immunity, University College London, UK; NIHR Biomedical Research Center at University College London Hospitals NHS Foundation Trust, London, UK.
5
Fondation Congolaise pour la Recherche Médicale (FCRM), Brazzaville, Congo; Faculty of Sciences and Techniques, University Marien Ngouabi, Brazzaville, Congo; Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany. Electronic address: francine.ntoumi@uni-tuebingen.de.

Abstract

The HIV epidemic continues to be a major global public health issue. Since 2012, there has been a paucity of information from the Republic of the Congo on HIV incidence and prevalence rates, national HIV programme effectiveness, highly active antiretroviral therapy (HAART) rollout, patient adherence to treatment, operational and basic science research studies on HIV/AIDS, and donor funding and its impact on the country. A review of the existing literature on HIV in the Republic of the Congo was conducted, focused on prevalence trends, effectiveness of the current national HIV programme, HAART rollout, patient adherence to antiretrovirals (ARVs), resistance to ARVs, the cost of treatment, and operational issues affecting HIV/AIDS programmes in the country. In light of the findings, several important priority areas for scaling-up HIV/AIDS services, programmatic and research activities in the Republic of the Congo are highlighted.

KEYWORDS:

AIDS; ARV; Coverage; HAART; HIV; Impact; Republic of the Congo; Treatment

PMID:
30342250
DOI:
10.1016/j.ijid.2018.10.009
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center